An American company called 'Disruptive Nanotechnology
(trading as Tried and Tested), which had two employees - Charles Palmer and Kim
Thonger - no assets, £85 in the bank, and debts of £3,592, made a £20 million
profit from government contracts after it was referred to the VIP fast track
lane by Dominic Cummings at the height of the COVID pandemic.
In July 2020, Dominic Cummings referred an offer from two
middlemen, Palmer and Thonger, representing the US-based firm Innova Medical
Group, within one hour of receiving it by email to a No.10 advisor. Less than
two months later, Innova was awarded its first public contact without
competition, valued at £103 million. Innova went on to win 12 contracts to
supply COVID tests totalling more than £4 billion in value.
In June 2021, U.S. regulators banned the use of Innova COVID
tests due to "significant concerns
that the performance of the test has not been adequately established,
presenting a risk to health." The U.S. regulators also suggested that
Innova may have falsified evidence in support of the efficacy of the tests.
Consumers were advised to either "destroy" Innova's antigen tests or
throw them in the "trash". Six days later the Conservative government
of Boris Johnson, awarded Innova a further contract valued at £518 million.
The lucrative government contracts with Innova saw Disruptive
Nanotechnology's profits surge in 2020/21 to £20.5 million. Palmer and Thonger
were the company's only employees at the time. Innova Medical Group also cashed
in during the pandemic with executives buying Gulfstream jets and purchasing
'multi-million dollar homes directly off the back of the contracts awarded by
the British government.
An organisation called the Good Law Project, contacted No. 10
Downing Street, the Department of Health and Social Care, Innova and Disruptive
Nanotechnology, for an explanation as to how a tiny company with no assets,
selling a dubious product, won privileged access to the heart of government. No
explanation has been forthcoming.
No comments:
Post a Comment